Interval debulking surgery is not worth the wait: a National Cancer Database study comparing primary cytoreductive surgery versus neoadjuvant chemotherapy

TRUST: Trial of Radical Upfront Surgical Therapy in advanced ovarian cancer (ENGOT ov33/AGO‐OVAR OP7)

(2019) Alexander Reuss et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

Role of Neoadjuvant Chemotherapy in Advanced Epithelial Ovarian Cancer

(2019) Andreas du Bois et al.   JOURNAL OF CLINICAL ONCOLOGY

Effect of adoption of neoadjuvant chemotherapy for advanced ovarian cancer on all cause mortality: quasi-experimental study

(2018) Alexander Melamed et al.   BMJ-British Medical Journal

Effect of adoption of neoadjuvant chemotherapy for advanced ovarian cancer on all cause mortality: quasi-experimental study

(2018) Alexander Melamed et al.   BMJ-British Medical Journal

Survival analyses from a randomized trial of primary debulking surgery versus neoadjuvant chemotherapy for advanced epithelial ovarian cancer with high tumor load (SCORPION trial).

(2018) Anna Fagotti et al.   JOURNAL OF CLINICAL ONCOLOGY

Comparison of survival between upfront primary debulking surgery versus neoadjuvant chemotherapy for stage III/IV ovarian, tubal and peritoneal cancers in phase III randomized trial: JCOG0602.

(2018) Takashi ONDA et al.   JOURNAL OF CLINICAL ONCOLOGY

Laparoscopy to Predict the Result of Primary Cytoreductive Surgery in Patients With Advanced Ovarian Cancer: A Randomized Controlled Trial

(2017) Marianne J. Rutten et al.   JOURNAL OF CLINICAL ONCOLOGY

Neoadjuvant chemotherapy versus primary debulking surgery in advanced epithelial ovarian cancer: A meta-analysis of peri-operative outcome

(2017) Lijuan Yang et al.   PLoS One

Predicting Surgical Outcome in Patients With International Federation of Gynecology and Obstetrics Stage III or IV Ovarian Cancer Using Computed Tomography

(2015) Marianne Jetske Rutten et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial

(2015) Sean Kehoe et al.   LANCET

MatchIt: Nonparametric Preprocessing for Parametric Causal Inference

(2015) Daniel E. Ho et al.   Journal of Statistical Software

Risk Prediction for Late-Stage Ovarian Cancer by Meta-analysis of 1525 Patient Samples

(2014) Markus Riester et al.   JNCI-Journal of the National Cancer Institute

Is perioperative visual estimation of intra-abdominal tumor spread reliable in ovarian cancer surgery after neoadjuvant chemotherapy?

(2012) Johanna Hynninen et al.   GYNECOLOGIC ONCOLOGY

Thirty-Day Mortality After Primary Cytoreductive Surgery for Advanced Ovarian Cancer in the Elderly

(2011) Melissa M. Thrall et al.   OBSTETRICS AND GYNECOLOGY

Identification of patient groups at highest risk from traditional approach to ovarian cancer treatment

(2010) Giovanni D. Aletti et al.   GYNECOLOGIC ONCOLOGY

Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer

(2010) Ignace Vergote et al.   NEW ENGLAND JOURNAL OF MEDICINE